Nasim A. Khan

1.8k total citations
50 papers, 1.1k citations indexed

About

Nasim A. Khan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Nasim A. Khan has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Rheumatology. Recurrent topics in Nasim A. Khan's work include Rheumatoid Arthritis Research and Therapies (8 papers), Fungal and yeast genetics research (6 papers) and Pharmaceutical industry and healthcare (5 papers). Nasim A. Khan is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Fungal and yeast genetics research (6 papers) and Pharmaceutical industry and healthcare (5 papers). Nasim A. Khan collaborates with scholars based in United States, Japan and Saudi Arabia. Nasim A. Khan's co-authors include Norman R. Eaton, Fawad Aslam, Karina D. Torralba, James A. Kruse, Noboru Oriuchi, Keigo Endo, Horace J. Spencer, Tetsuya Higuchi, Mahboob Alam and Salman Bandeali and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Renewable and Sustainable Energy Reviews.

In The Last Decade

Nasim A. Khan

48 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nasim A. Khan United States 20 229 224 176 118 115 50 1.1k
Jong-Tae Lee South Korea 20 129 0.6× 108 0.5× 94 0.5× 225 1.9× 144 1.3× 128 1.3k
John McCormick United States 21 419 1.8× 269 1.2× 227 1.3× 174 1.5× 82 0.7× 39 1.8k
Richard M. Kaufman United States 31 144 0.6× 266 1.2× 53 0.3× 182 1.5× 82 0.7× 100 3.3k
Muhammed Mubarak Pakistan 23 177 0.8× 312 1.4× 178 1.0× 379 3.2× 110 1.0× 271 2.0k
Ping Liu China 23 105 0.5× 225 1.0× 240 1.4× 168 1.4× 113 1.0× 150 2.0k
Tor Hervig Norway 31 83 0.4× 164 0.7× 104 0.6× 145 1.2× 52 0.5× 157 2.9k
Venkatraman Radhakrishnan India 22 260 1.1× 225 1.0× 64 0.4× 322 2.7× 98 0.9× 196 1.7k
Ronit Almog Israel 21 117 0.5× 339 1.5× 117 0.7× 250 2.1× 193 1.7× 68 2.2k
Meng Yang China 22 156 0.7× 149 0.7× 58 0.3× 275 2.3× 148 1.3× 106 1.4k
Arun S. Shet United States 22 128 0.6× 694 3.1× 97 0.6× 197 1.7× 78 0.7× 61 2.4k

Countries citing papers authored by Nasim A. Khan

Since Specialization
Citations

This map shows the geographic impact of Nasim A. Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasim A. Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasim A. Khan more than expected).

Fields of papers citing papers by Nasim A. Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasim A. Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasim A. Khan. The network helps show where Nasim A. Khan may publish in the future.

Co-authorship network of co-authors of Nasim A. Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Nasim A. Khan. A scholar is included among the top collaborators of Nasim A. Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasim A. Khan. Nasim A. Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saleh, Jamal Al, et al.. (2024). Prevalence of comorbidities among patients with rheumatoid arthritis in the UAE: a case–control study. BMJ Open. 14(11). e086116–e086116. 1 indexed citations
2.
Wayant, Cole, Lisa Cosgrove, Elie A. Akl, et al.. (2020). Ten years later: a review of the US 2009 institute of medicine report on conflicts of interest and solutions for further reform. BMJ evidence-based medicine. 27(1). 46–54. 20 indexed citations
4.
Aslam, Fawad & Nasim A. Khan. (2018). Tools for the Assessment of Comorbidity Burden in Rheumatoid Arthritis. Frontiers in Medicine. 5. 39–39. 38 indexed citations
5.
Khan, Nasim A., Horace J. Spencer, Elena Nikiphorou, et al.. (2017). Intercentre variance in patient reported outcomes is lower than objective rheumatoid arthritis activity measures: a cross-sectional study. Lara D. Veeken. 56(8). 1395–1400. 3 indexed citations
6.
Sun, Jinchun, Yukio Ando, Laura K. Schnackenberg, et al.. (2012). Serum metabolomic profiles from patients with acute kidney injury: A pilot study. Journal of Chromatography B. 893-894. 107–113. 75 indexed citations
7.
Khan, Nasim A. & Manisha Singh. (2012). Development of anti-neutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves’ disease independent of anti-thyroid drug therapy. Modern Rheumatology. 22(5). 778–782. 2 indexed citations
8.
Aslam, Fawad, Salman Bandeali, Nasim A. Khan, & Mahboob Alam. (2012). Diastolic Dysfunction in Rheumatoid Arthritis: A Meta‐Analysis and Systematic Review. Arthritis Care & Research. 65(4). 534–543. 72 indexed citations
9.
Khan, Nasim A., et al.. (2012). Multiple Digital Gangrene and Polyuria. Mayo Clinic Proceedings. 87(4). e25–e25. 3 indexed citations
10.
Caplan, Liron, Lisa Davis, Gail S. Kerr, et al.. (2012). Body mass index and the rheumatoid arthritis swollen joint count: An observational study. Arthritis Care & Research. 65(1). 101–106. 23 indexed citations
11.
Sokka, Tuulikki, Tuomas Rannio, & Nasim A. Khan. (2012). Disease Activity Assessment and Patient-Reported Outcomes in Patients with Early Rheumatoid Arthritis. Rheumatic Disease Clinics of North America. 38(2). 299–310. 4 indexed citations
12.
Khan, Nasim A., et al.. (2005). Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer. Annals of Nuclear Medicine. 19(2). 137–145. 14 indexed citations
13.
Almoallim, Hani, et al.. (2005). Isolated eosinophilic mesenteric vasculitis with extensive thrombosis and splenic infarction in a 13-year-old boy. Clinical Rheumatology. 26(2). 254–257. 7 indexed citations
14.
Khan, Nasim A., et al.. (2005). Tubo-ovarian abscess in a postmenopausal woman with underlying ovarian carcinoma.. PubMed. 26(6). 1010–1. 3 indexed citations
15.
Khan, Nasim A., et al.. (2004). Positron emission tomographic imaging with11C-choline in differential diagnosis of head and neck tumors: comparison with18F-FDG PET. Annals of Nuclear Medicine. 18(5). 409–417. 37 indexed citations
16.
Shi, Qian, Qinghua Xiong, Bailiang Wang, et al.. (2000). Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis.. PubMed. 60(10). 2579–83. 84 indexed citations
17.
Khan, Nasim A.. (1985). Mitochondrial integrity and maltose utilization in yeast. Current Genetics. 10(2). 111–117. 2 indexed citations
18.
Khan, Nasim A.. (1982). Suppression of maltose-negative phenotype by a specific nuclear gene (PMU1) in the petite cells of the yeast Saccharomyces cerevisiae. Molecular and General Genetics MGG. 186(1). 40–43. 7 indexed citations
19.
Khan, Nasim A.. (1979). Genetic control of maltase synthesis in yeast. Molecular and General Genetics MGG. 172(3). 281–285. 10 indexed citations
20.
Khan, Nasim A.. (1975). Genetic control of maltase formation in yeast. Molecular and General Genetics MGG. 136(1). 55–61. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026